Page 30 - Sohini Das

Private hospitals write to health ministry over rate standardisation

Better insurance cover would enhance price transparency

Advent PE begins merger process of Suven Pharma and Cohance Lifesciences

The merged platform will have mid-30s EBITDA margins, 30 per cent Return on Capital Employed (RoCE) and stable cash flow generation over FY20-23, the statement said

Takeda injects hope: Dengue vaccine clinical trials set to begin in India

Biological E will increase manufacturing capacity to up to 50 million doses a year, accelerating Takeda's plans to manufacture 100 million doses annually within the decade

Several pharma cos step up corrective action plans after crackdown by govt

The orders in the state have now been revoked, with the companies undergoing corrective and preventive action (CAPA) processes

Skoda Auto India to drive in Brezza, Sonet rival in first half of 2025

Plans four EVs for India over next few years

Health care companies check market pulse with IPOs after pandemic

Noticeably, a large number of hospital chains have tapped the public markets. Some of them include Yatharth Hospital, Jupiter Life Line and Global Healthcare

Zydus Lifesciences gets WHO nod for API used in kala-azar treatment

More than 1 billion people live in areas endemic for leishmaniasis or Kala Azar and are at risk of infection

Preventive and wellness tests drive growth for diagnostic companies

Covid-19 led to increase in self-testing awareness, particularly about preventive and wellness services

Indian drug firms look for new opportunities in Saudi Arabia pharma market

Indian drug firms sense opportunity to increase presence in $8.9 bn Saudi market

Zoomcar Q3 results: Revenue slips 19% to $2.4 mn, bottomline improves

The firm said that net revenue declined due to lower number of days booked, resulting in decreased gross billings as Zoomcar prioritised higher-margin bookings in support of its cost reduction efforts

Tractor industry sales likely to dip 5% due to agri activities slowdown

The market leader in tractors in India, Mahindra and Mahindra, felt that the year would end with around 900,000 units in sales compared to 945,000 units sold in 2022-23

M&M Q3 results: PAT at Rs 2,658 cr on strong auto market share gains

The company's stock gained close to one per cent on BSE on Wednesday

Commercial vehicle sales likely to enter into a downcycle in 2024-25

Volumes are expected to dip by 4-7 percent

Passenger vehicles wholesales grow 14% in Jan, retail catches up

'Positive consumer sentiment' leads to best number for that month, says SIAM

Tata Nexon secures 5-star rating in latest Global NCAP crash tests

Nexon received a score of 32.22 out of 34 points for adult occupant protection and 44.52 out of 49 points for child occupant protection

Eye on affordability? Tata Motors latest to slash prices of electric cars

Tata Motors slashes prices of Nexon, Tiago EVs by up to Rs 1.2 lakh

Auto components sector growth may ease to 5-7% in FY25, says ICRA

On the EV front, there is significant opportunity. At present, only 30-40 percent of the EV supply chain is localised

PE majors Blackstone, ChrysCapital join race to buy Healthium Medtech

The company is generating good response from the potential bidders as it is focusing primarily on products in surgical and post surgical as well as chronic care

Bharat Forge Q3 results: Profit up over 220% to Rs 254 cr, stock tanks 14%

The company's stock slid 14.04 per cent on the Bombay Stock Exchange (BSE) on Monday, ending the day's trade at Rs 1,130.3 apiece

In next 4-5 years, we aim capex of Rs 1,500 cr: Biocon's Siddharth Mittal

Siddharth Mittal outlines the growth strategies and challenges ahead